The global dermatologicals market accounted for $15,563 million in 2018 and is expected to reach $36,205 million by 2026, registering a CAGR of 10.9% from 2019 to 2026.
Dermatology is a field of medicine that is engaged in the diagnosis, prevention, and treatment of various diseases related to skin, nails, and hair, such as pigmentation, acne, wrinkles, and psoriasis. Dermatological agents, also known as dermatologicals, are products which are applied topically on the skin. These products are used to treat skin conditions and are also employed to prevent certain skin disorders. Furthermore, dermatologicals are also used for routine skin care to maintain one’s skin. However, some of the dermatologicals are systemic preparations, which are used in patients who are not responsive to topical medications. Moreover, these preparations are used to treat various skin conditions such as acne, dermatitis, and psoriasis.
The major factor that contributes to the growth of dermatologicals market include rise in demand for topical dermatological drugs such as anti-inflammatory agents, anti-infective, local anesthetics, cleansers, and emollients to treat acne. Furthermore, the rise in awareness about skin diseases, high demand for rapid diagnosis, and surge in incidence of skin cancer and other skin disorders are the factors that boost the growth of the dermatologicals market. However, lack of awareness about the drugs and stringent government regulations restrain the dermatologicals market growth. The development of innovative products and increase in number of mergers & acquisitions by key vendors are expected to provide numerous opportunities for the market growth during the forecast period.
The global dermatologicals market is highly competitive and the prominent players in the market have adopted various strategies to garner maximum market share. These include collaboration, product launch, partnership, and acquisition. Major players operating in the market include Bayer AG, Johnson & Johnson, Pfizer Inc., Novartis AG, GlaxoSmithKline plc, AstraZeneca, Galderma S.A., Amgen Inc., AbbVie Inc., and Merck KGaA.
Key Market Segments:
By Dermatological Disease
By Drug Type
By Route of Administration
By Region
The Dermatologicals market research report covers definition, classification, product classification, product application, development trend, product technology, competitive landscape, industrial chain structure, industry overview, national policy and planning analysis of the industry, the latest dynamic analysis, etc., and also includes major. The study includes drivers and restraints of the global market. It covers the impact of these drivers and restraints on the demand during the forecast period. The report also highlights opportunities in the market at the global level.
The report provides size (in terms of volume and value) of Dermatologicals market for the base year 2019 and the forecast between 2020 and 2027. Market numbers have been estimated based on form and application. Market size and forecast for each application segment have been provided for the global and regional market.
This report focuses on the global Dermatologicals market status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Dermatologicals market development in United States, Europe and China.
It is pertinent to consider that in a volatile global economy, we haven’t just conducted Dermatologicals market forecasts in terms of CAGR, but also studied the market based on key parameters, including Year-on-Year (Y-o-Y) growth, to comprehend the certainty of the market and to find and present the lucrative opportunities in market.
In terms of production side, this report researches the Dermatologicals capacity, production, value, ex-factory price, growth rate, market share for major manufacturers, regions (or countries) and type.
In terms of consumption side, this report focuses on the consumption of Dermatologicals by regions (countries) and application.
Buyers of the report will have access to verified market figures, including global market size in terms of revenue and volume. As part of production analysis, the authors of the report have provided reliable estimations and calculations for global revenue and volume by Type segment of the global Dermatologicals market. These figures have been provided in terms of both revenue and volume for the period 2016 to 2027. Additionally, the report provides accurate figures for production by region in terms of revenue as well as volume for the same period. The report also includes production capacity statistics for the same period.
With regard to production bases and technologies, the research in this report covers the production time, base distribution, technical parameters, research and development trends, technology sources, and sources of raw materials of major Dermatologicals market companies.
Regarding the analysis of the industry chain, the research of this report covers the raw materials and equipment of Dermatologicals market upstream, downstream customers, marketing channels, industry development trends and investment strategy recommendations. The more specific analysis also includes the main application areas of market and consumption, major regions and Consumption, major Chinese producers, distributors, raw material suppliers, equipment providers and their contact information, industry chain relationship analysis.
The research in this report also includes product parameters, production process, cost structure, and data information classified by region, technology and application. Finally, the paper model new project SWOT analysis and investment feasibility study of the case model.
Overall, this is an in-depth research report specifically for the Dermatologicals industry. The research center uses an objective and fair way to conduct an in-depth analysis of the development trend of the industry, providing support and evidence for customer competition analysis, development planning, and investment decision-making. In the course of operation, the project has received support and assistance from technicians and marketing personnel in various links of the industry chain.
Dermatologicals market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies’ focus related to Dermatologicals market.
Prominent players in the market are predicted to face tough competition from the new entrants. However, some of the key players are targeting to acquire the startup companies in order to maintain their dominance in the global market. For a detailed analysis of key companies, their strengths, weaknesses, threats, and opportunities are measured in the report by using industry-standard tools such as the SWOT analysis. Regional coverage of key companies is covered in the report to measure their dominance. Key manufacturers of Dermatologicals market are focusing on introducing new products to meet the needs of the patrons. The feasibility of new products is also measured by using industry-standard tools.
Key companies are increasing their investments in research and development activities for the discovery of new products. There has also been a rise in the government funding for the introduction of new Dermatologicals market. These factors have benefited the growth of the global market for Dermatologicals. Going forward, key companies are predicted to benefit from the new product launches and the adoption of technological advancements. Technical advancements have benefited many industries and the global industry is not an exception.
New product launches and the expansion of already existing business are predicted to benefit the key players in maintaining their dominance in the global market for Dermatologicals. The global market is segmented on the basis of region, application, en-users and product type. Based on region, the market is divided into North America, Europe, Asia-Pacific, Latin America and Middle East and Africa (MEA).
In this study, the years considered to estimate the market size of Dermatologicals are as follows:
Reasons to Purchase this Report:
- Market segmentation analysis including qualitative and quantitative research incorporating the impact of economic and policy aspects
- Regional and country level analysis integrating the demand and supply forces that are influencing the growth of the market.
- Market value USD Million and volume Units Million data for each segment and sub-segment
- Competitive landscape involving the market share of major players, along with the new projects and strategies adopted by players in the past five years
- Comprehensive company profiles covering the product offerings, key financial information, recent developments, SWOT analysis, and strategies employed by the major market players
Research Methodology:
In-depth interviews and discussions were conducted with several key market participants and opinion leaders to compile the research report.
This research study involved the extensive usage of both primary and secondary data sources. The research process involved the study of various factors affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry, and market risks, opportunities, market barriers and challenges. The following illustrative figure shows the market research methodology applied in this report.
Market Size Estimation
Top-down and bottom-up approaches are used to estimate and validate the global market size for company, regional division, product type and application (end users).
The market estimations in this report are based on the selling price (excluding any discounts provided by the manufacturer, distributor, wholesaler or traders). Market share analysis, assigned to each of the segments and regions are achieved through product utilization rate and average selling price.
Major manufacturers & their revenues, percentage splits, market shares, growth rates and breakdowns of the product markets are determined through secondary sources and verified through the primary sources.
All possible factors that influence the markets included in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data. The market size for top-level markets and sub-segments is normalized, and the effect of inflation, economic downturns, and regulatory & policy changes or others factors are accounted for in the market forecast. This data is combined and added with detailed inputs and analysis from Vision Research Reports and presented in this report.
Market Breakdown and Data Triangulation
After complete market engineering with calculations for market statistics; market size estimations; market forecasting; market breakdown; and data triangulation. Extensive primary research was conducted to gather information and verify and validate the critical numbers arrived at. In the complete market engineering process, both top-down and bottom-up approaches were extensively used, along with several data triangulation methods, to perform market estimation and market forecasting for the overall market segments and sub-segments listed in this report.
Secondary Sources
Secondary Sources occupies approximately 25% of data sources, such as press releases, annual reports, Non-Profit organizations, industry associations, governmental agencies and customs data, and so on. This research study includes secondary sources; directories; databases such as Bloomberg Business, Wind Info, Hoovers, Factiva (Dow Jones & Company), TRADING ECONOMICS, and avention; Investing News Network; statista; Federal Reserve Economic Data; annual reports; investor presentations; and SEC filings of companies.
Primary Sources
In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include product manufacturers (and their competitors), opinion leaders, industry experts, research institutions, distributors, dealer and traders, as well as the raw materials suppliers and producers, etc.
The primary sources from the demand side include industry experts such as business leaders, marketing and sales directors, technology and innovation directors, supply chain executive, end users (product buyers), and related key executives from various key companies and organizations operating in the global market.
The study objectives of this report are:
Table of Content
CHAPTER 1: INTRODUCTION
1.1. Report description
1.2. Key market segments
1.2.1. List of key players profiled in the report
1.3. Research methodology
1.3.1. Primary research
1.3.2. Secondary research
1.3.3. Analyst tools and models
CHAPTER 2: EXECUTIVE SUMMARY
2.1. Key findings of the study
2.2. CXO perspective
CHAPTER 3: MARKET OVERVIEW
3.1. Market definition and scope
3.2. Top player positioning
3.2.1. Top investment pockets
3.3. Key forces shaping dermatologicals industry/market
3.4. Market dynamics
3.4.1. Drivers
3.4.1.1. Increase in prevalence of skin disorders
3.4.1.2. Surge in healthcare expenditure worldwide
3.4.1.3. Rise in focus on skin care products
3.4.2. Restraint
3.4.2.1. Presence of alternatives for acne treatment
3.4.3. Opportunity
3.4.3.1. High growth potential in developing economies
3.4.4. Impact Analyses
CHAPTER 4: DERMATOLOGICALS MARKET, BY DISEASE
4.1. Overview
4.1.1. Market size and forecast
4.2. Acne
4.2.1. Key market trends, growth factors, and opportunities
4.2.2. Market size and forecast, by region
4.2.3. Market analysis, by country
4.3. Dermatitis
4.3.1. Key market trends, growth factors, and opportunities
4.3.2. Market size and forecast, by region
4.3.3. Market analysis, by country
4.4. Psoriasis
4.4.1. Key market trends, growth factors, and opportunities
4.4.2. Market size and forecast, by region
4.4.3. Market analysis, by country
4.5. Skin Cancer
4.5.1. Key market trends, growth factors, and opportunities
4.5.2. Market size and forecast, by region
4.5.3. Market analysis, by country
4.6. Rosacea
4.6.1. Key market trends, growth factors, and opportunities
4.6.2. Market size and forecast, by region
4.6.3. Market analysis, by country
4.7. Alopecia
4.7.1. Key market trends, growth factors, and opportunities
4.7.2. Market size and forecast, by region
4.7.3. Market analysis, by country
4.8. Others
4.8.1. Key market trends, growth factors, and opportunities
4.8.2. Market size and forecast, by region
4.8.3. Market analysis, by country
CHAPTER 5: DERMATOLOGICALS MARKET, BY TYPE
5.1. Overview
5.1.1. Market size and forecast
5.2. Prescription-Based Drugs
5.2.1. Market size and forecast, by region
5.2.2. Market analysis, by country
5.3. Over-the-Counter Drugs
5.3.1. Market size and forecast, by region
5.3.2. Market analysis, by country
CHAPTER 6: DERMATOLOGICALS MARKET, BY ROUTE OF ADMINSTRATION
6.1. Overview
6.1.1. Market size and forecast
6.2. Topical Administration
6.2.1. Market size and forecast, by region
6.2.2. Market analysis, by country
6.3. Oral Administration
6.3.1. Market size and forecast, by region
6.3.2. Market analysis, by country
6.4. Parenteral Administration
6.4.1. Market size and forecast, by region
6.4.2. Market analysis, by country
CHAPTER 7: DERMATOLOGICALS MARKET, BY REGION
7.1. Overview
7.1.1. Market size and forecast
7.2. North America
7.2.1. Key market trends and opportunities
7.2.2. Market analysis, by country
7.2.2.1. U.S.
7.2.2.1.1. U.S. market size and forecast, by disease
7.2.2.1.2. U.S. market size and forecast, by type
7.2.2.1.3. U.S. market size and forecast, by route of administration
7.2.2.2. Canada
7.2.2.2.1. Canada market size and forecast, by disease
7.2.2.2.2. Canada market size and forecast, by type
7.2.2.2.3. Canada market size and forecast, by route of administration
7.2.2.3. Mexico
7.2.2.3.1. Mexico market size and forecast, by disease
7.2.2.3.2. Mexico market size and forecast, by type
7.2.2.3.3. Mexico market size and forecast, by route of administration
7.2.3. North America market size and forecast, by disease
7.2.4. North America market size and forecast, by type
7.2.5. North America market size and forecast, by route of administration
7.3. Europe
7.3.1. Key market trends and opportunities
7.3.2. Market analysis, by country
7.3.2.1. Germany
7.3.2.1.1. Germany market size and forecast, by disease
7.3.2.1.2. Germany market size and forecast, by type
7.3.2.1.3. Germany market size and forecast, by route of administration
7.3.2.2. France
7.3.2.2.1. France market size and forecast, by disease
7.3.2.2.2. France market size and forecast, by type
7.3.2.2.3. France market size and forecast, by route of administration
7.3.2.3. UK
7.3.2.3.1. UK market size and forecast, by dermatological disease
7.3.2.3.2. UK market size and forecast, by type
7.3.2.3.3. UK market size and forecast, by route of administration
7.3.2.4. Italy
7.3.2.4.1. Italy market size and forecast, by dermatological disease
7.3.2.4.2. Italy market size and forecast, by type
7.3.2.4.3. Italy market size and forecast, by route of administration
7.3.2.5. Rest of Europe
7.3.2.5.1. Rest of Europe market size and forecast, by dermatological disease
7.3.2.5.2. Rest of Europe market size and forecast, by type
7.3.2.5.3. Rest of Europe market size and forecast, by route of administration
7.3.3. Europe market size and forecast, by dermatological disease
7.3.4. Europe market size and forecast, by type
7.3.5. Europe market size and forecast, by route of administration
7.4. Asia-Pacific
7.4.1. Key market trends and opportunities
7.4.2. Market analysis, by country
7.4.2.1. Japan
7.4.2.1.1. Japan market size and forecast, by dermatological disease
7.4.2.1.2. Japan market size and forecast, by type
7.4.2.1.3. Japan market size and forecast, by route of administration
7.4.2.2. China
7.4.2.2.1. China market size and forecast, by dermatological disease
7.4.2.2.2. China market size and forecast, by type
7.4.2.2.3. China market size and forecast, by route of administration
7.4.2.3. India
7.4.2.3.1. India market size and forecast, by dermatological disease
7.4.2.3.2. India market size and forecast, by type
7.4.2.3.3. India market size and forecast, by route of administration
7.4.2.4. Rest of Asia-Pacific
7.4.2.4.1. Rest of Asia-Pacific market size and forecast, by dermatological disease
7.4.2.4.2. Rest of Asia-Pacific market size and forecast, by type
7.4.2.4.3. Rest of Asia-Pacific market size and forecast, by route of administration
7.4.3. Asia-Pacific market size and forecast, by dermatological disease
7.4.4. Asia-Pacific market size and forecast, by type
7.4.5. Asia-Pacific market size and forecast, by route of administration
7.5. LAMEA
7.5.1. Key market trends and opportunities
7.5.2. Market analysis, by country
7.5.2.1. Brazil
7.5.2.1.1. Brazil market size and forecast, by dermatological disease
7.5.2.1.2. Brazil market size and forecast, by type
7.5.2.1.3. Brazil market size and forecast, by route of administration
7.5.2.2. South Africa
7.5.2.2.1. South Africa market size and forecast, by dermatological disease
7.5.2.2.2. South Africa market size and forecast, by type
7.5.2.2.3. South Africa market size and forecast, by route of administration
7.5.2.3. Saudi Arabia
7.5.2.3.1. Saudi Arabia market size and forecast, by dermatological disease
7.5.2.3.2. Saudi Arabia market size and forecast, by type
7.5.2.3.3. Saudi Arabia market size and forecast, by route of administration
7.5.2.4. Rest of LAMEA
7.5.2.4.1. Rest of LAMEA market size and forecast, by dermatological disease
7.5.2.4.2. Rest of LAMEA market size and forecast, by type
7.5.2.4.3. Rest of LAMEA market size and forecast, by route of administration
7.5.3. LAMEA market size and forecast, by dermatological disease
7.5.4. LAMEA market size and forecast, by type
7.5.5. LAMEA market size and forecast, by route of administration
CHAPTER 8: COMPANY PROFILES
8.1. AbbVie Inc.
8.1.1. Company overview
8.1.2. Company snapshot
8.1.3. Operating business segments
8.1.4. Product portfolio
8.1.5. Business performance
8.2. AstraZeneca plc
8.2.1. Company overview
8.2.2. Company snapshot
8.2.3. Operating business segments
8.2.4. Product portfolio
8.2.5. Business performance
8.2.6. Key strategic moves and developments
8.3. Amgen Inc.
8.3.1. Company overview
8.3.2. Company snapshot
8.3.3. Operating business segments
8.3.4. Product portfolio
8.3.5. Business performance
8.4. GlaxoSmithKline Plc.
8.4.1. Company overview
8.4.2. Company snapshot
8.4.3. Operating business segments
8.4.4. Product portfolio
8.4.5. Business performance
8.5. Johnson & Johnson
8.5.1. Company overview
8.5.2. Company snapshot
8.5.3. Operating business segments
8.5.4. Product portfolio
8.5.5. Business performance
8.6. Leo Pharma A/S
8.6.1. Company overview
8.6.2. Company snapshot
8.6.3. Operating business segments
8.6.4. Product portfolio
8.6.5. Business performance
8.6.6. Key strategic moves and developments
8.7. Merck KGaA
8.7.1. Company overview
8.7.2. Company snapshot
8.7.3. Operating business segments
8.7.4. Product portfolio
8.7.5. Business performance
8.8. Nestlé S.A
8.8.1. Company overview
8.8.2. Operating business segments
8.8.3. Business performance
8.9. Novartis AG
8.9.1. Company overview
8.9.2. Company snapshot
8.9.3. Operating business segments
8.9.4. Product portfolio
8.9.5. Business performance
8.10. Pfizer Inc.
8.10.1. Company overview
8.10.2. Company snapshot
8.10.3. Operating business segments
8.10.4. Product portfolio
8.10.5. Business performance
Cross-segment Market Size and Analysis for
Mentioned Segments
Additional Company Profiles (Upto 5 With No Cost)
Additional Countries (Apart From Mentioned Countries)
Country/Region-specific Report
Go To Market Strategy
Region Specific Market DynamicsRegion Level Market Share Import Export AnalysisProduction AnalysisOthers